Country: Malta
Language: English
Source: Medicines Authority
moxonidine 0.4 mg
Abbott Healthcare Products Limited
C02AC05
moxonidine
film-coated tablet
Authorised
2006-01-16
Package Leaflet: Information for the user PHYSIOtens ® Film-coated tablets 200 micrograms, 300 micrograms and 400 micrograms MOXONIDINE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects becomes serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Physiotens is and what it is used for 2. Before you take Physiotens 3. How to take Physiotens 4. Possible side effects 5. How to store Physiotens 6. Further information 1.What Physiotens is and what it is used for ? Physiotens contains a medicine called moxonidine. This medicine belongs to a group of medicines called “anti-hypertensives”. Physiotens is used to treat high blood pressure (hypertension). It works by making your blood vessels relax and widen. This helps to lower your blood pressure. 2. Before you take Physiotens DO NOT TAKE PHYSIOTENS IF: • you are allergic (hypersensitive) to moxonidine or any of the other ingredients of Physiotens (listed in Section 6) • you have a slow heart rate caused by a heart problem called “sick sinus syndrome” or “2 nd or 3 rd degree AV- block” • you have heart failure. • you have serious kidney problems Do not take Physiotens if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Physiot Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Physiotens ® Tablets 400 micrograms 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 400 micrograms moxonidine. Excipients: 95.6 mg lactose per tablet For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablets. Dull red, round, biconvex, film-coated tablets imprinted ‘0.4’ on one face. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mild to moderate essential or primary hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults (including the elderly):_ Treatment should be started with 200 micrograms of Physiotens in the morning. The dose may be titrated after three weeks to 400 micrograms, given as one dose or as divided doses (morning and evening) until a satisfactory response has been achieved. If the response is still unsatisfactory after a further three weeks’ treatment, the dosage can be increased up to a maximum of 600 micrograms in divided doses (morning and evening). A single dose of 400 micrograms of Physiotens and a daily dose of 600 micrograms in divided doses (morning and evening) should not be exceeded. In patients with moderate renal dysfunction (GFR above 30 ml/min, but below 60 ml/min), the single dose should not exceed 200 micrograms and the daily dose should not exceed 400 micrograms of moxonidine. The tablets should be taken with a little liquid. As the intake of food has no influence on the pharmacokinetic properties of moxonidine, the tablets may be taken before, during or after the meal. Paediatric population Physiotens is not recommended for use in children and adolescents below 18 years due to l Read the complete document